Immune to Cancer: The CRI Blog
-
Head and Neck Cancer Awareness Month: 2022 Immunotherapy Research Updates
This April for Head and Neck Cancer Awareness Month, discover the new research, new treatments, and progress…
-
Dr. Nabil F. Saba Answers Questions About Head and Neck Cancer and Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Nabil F. Saba, of Winship Cancer Institute at Emory University, answers questions about immunotherapy for head…
-
Head and Neck Cancer Awareness Month: 2021 Immunotherapy Research Updates
This April for Head and Neck Cancer Awareness Month, we look at new research, new treatments, and…
-
Head and Neck Cancer Awareness Month: 2020 Immunotherapy Research Update
HPV’s connection to head and neck cancer, treatment options, side effects, and how we’re working toward a…
-
FDA Approves Pembrolizumab (Keytruda®), a PD-1 Antibody, for Head and Neck Cancer
New hope now exists for patients with advanced head and neck cancer.
-
ASCO 2016 Update: Immunotherapy’s Impact in Head & Neck Cancers
Immunotherapy approaches provide improvements for patients with head and neck cancer.
-
#AACR16 Update: New Hope for Patients with Rare Skin Cancer, Head & Neck Cancer
Anti-PD-1 blockade and two other types of immunotherapy effective in treating multiple tumor types.